Parents' experiences on the combined use of continuous subcutaneous insulin infusion and real-time continuous glucose monitoring to manage Type 1 diabetes in their children: A systematic review and meta-synthesis of qualitative studies.

This is a qualitative evidence synthesis, so it reports parents' experiences and cannot show whether the devices improve glycaemic control, safety, or quality of life. Some included studies also involved adults, adolescents, healthcare providers, and partners, and the authors said these data could not always be separated from parent data. Only English-language studies were searched, and grey literature was excluded, so experiences from non-English-speaking settings may be missing. The included studies came from the USA, UK, Canada, and Germany, so findings may not transfer to Chinese families, where the paper says the technology is mainly used in clinical research. Diabetes technology changed rapidly over the review period, so device experiences may not match current systems.

The authors declared no conflicts of interest.

Do not read this as evidence that combined pump and CGM improves glycaemic control or quality of life. It synthesises parents' reported experiences, and the themes include both benefits and burdens.